Guizhou Yibai Pharmaceutical Co Ltd Class A 600594
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 4.32
- Day Range
- CNY 4.23–4.31
- 52-Week Range
- CNY 3.77–6.35
- Bid/Ask
- CNY 4.23 / CNY 4.24
- Market Cap
- CNY 3.35 Bil
- Volume/Avg
- 8.6 Mil / 12.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.24
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 5,509
- Website
- http://www.gzcci.com
Comparables
Valuation
|
Metric
|
600594
|
600557
|
000623
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 22.15 | 13.66 |
Price/Book Value | 1.12 | 2.18 | 0.64 |
Price/Sales | 1.24 | 2.35 | 4.90 |
Price/Cash Flow | 8.10 | 8.82 | 60.39 |
Price/Earnings
600594
600557
000623
Financial Strength
|
Metric
|
600594
|
600557
|
000623
|
|---|---|---|---|
Quick Ratio | 1.25 | 2.19 | 1.32 |
Current Ratio | 1.90 | 2.52 | 1.60 |
Interest Coverage | 1.12 | — | 7.69 |
Quick Ratio
600594
600557
000623
Profitability
|
Metric
|
600594
|
600557
|
000623
|
|---|---|---|---|
Return on Assets (Normalized) | −0.72% | 7.20% | 3.56% |
Return on Equity (Normalized) | −1.13% | 9.86% | 4.21% |
Return on Invested Capital (Normalized) | −0.39% | 9.16% | 4.09% |
Return on Assets
600594
600557
000623
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Cckrypfdx | Dmxb | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Ljpfvzvzhw | Zlylly | $72.9 Bil | |
HLN
| Haleon PLC ADR | Xzdvdtclh | Tvz | $37.5 Bil | |
VTRS
| Viatris Inc | Xmkypfrvq | Fwd | $13.3 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Cvnvjls | Qfql | $11.7 Bil | |
CTLT
| Catalent Inc | Vkhblnwj | Cptsns | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Knfyhvm | Xxgdt | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Smzqzghkb | Zvq | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vytzqtwjv | Zmpcp | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Rwbfstccj | Lhcv | $3.0 Bil |